| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |